Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jamie Rijmers
Observed name:
J. Rijmers
Institution:
The Netherlands Cancer Institute
Observed institution:
The Netherlands Cancer Institute
ORCID:
0009-0009-2131-7422
Observed ORCID:
0009-0009-2131-7422
OpenAlex ID:
A5015979847
Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors
2025
·
Asael Roichman
, Qianying Zuo
, et al.
·
Cell
·
39
Resistance mutations and the blood–brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer
2025
·
Jamie Rijmers
, Maria C. Lebre
, et al.
·
Acta Pharmaceutica Sinica B
·
15
Pharmacokinetics of the KRASG12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c
2023
·
Nancy H.C. Loos
, Irene A. Retmana
, et al.
·
Biomedicine & Pharmacotherapy
·
15
ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure
2024
·
Jamie Rijmers
, Irene A. Retmana
, et al.
·
Biomedicine & Pharmacotherapy
·
9
Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue
2026
·
Davinia Arguedas
, Viët Bui
, et al.
·
Pharmacological Research
·
7
Brain Exposure to the Macrocyclic ALK Inhibitor Zotizalkib is Restricted by ABCB1, and Its Plasma Disposition is Affected by Mouse Carboxylesterase 1c
2024
·
Jamie Rijmers
, Rolf W. Sparidans
, et al.
·
Molecular Pharmaceutics
·
3
Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice
2024
·
Nancy H.C. Loos
, Margarida L. Ferreira Martins
, et al.
·
Molecular Pharmaceutics
·
3
Development and validation of an LC-MS/MS method for the quantification of KRASG12C inhibitor opnurasib in several mouse matrices and its application in a pharmacokinetic mouse study
2023
·
Irene A. Retmana
, Nefise Çelebi
, et al.
·
Journal of Chromatography B
·
3
Development and validation of an LC–MS/MS method for the quantification of the KRASG12C inhibitor divarasib
2026
·
Jamie Rijmers
, Viët Bui
, et al.
·
Journal of Chromatography B
·
1
Trsc-06 Characterization of a Non-small Cell Lung Cancer Ros1-fusion Brain Metastasis Model
2024
·
Jamie Rijmers
, Viët Bui
, et al.
·
Neuro-Oncology Advances
·
1
ABCB1, ABCG2, and CES1 are Key Determinants of the Pharmacokinetics of KRASG12C Inhibitor Divarasib
2026
·
Jamie Rijmers
, Viët Bui
, et al.
·
Molecular Pharmaceutics
Abstract B008: Pharmacokinetics of daraxonrasib (RMC-6236): transporter and enzyme impact on a first-in-class pan-RAS molecular glue
2026
·
Davinia Arguedas
, Viët Bui
, et al.
·
Cancer Research
59P The influence of the ABCB1, ABCG2 and OATP1 transporters and the CYP3A enzyme on the bioavailability and tissue distribution of TPX-0131
2023
·
J. Rijmers
, R. Sparidans
, et al.
·
ESMO Open
PDF
Show more works
View as search
Works count:
13
Citation count:
96
H-index:
5
I10-index:
3
Year
Topic
Type